Simplify Logo

Full-Time

Senior/Principal Scientist

Lung Cancer Research

Confirmed live in the last 24 hours

23andMe

23andMe

501-1,000 employees

Direct-to-consumer DNA testing services

Biotechnology
Healthcare
Consumer Goods

Compensation Overview

$160k - $240kAnnually

Senior, Expert

Sunnyvale, CA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD or MD with 5 years of research experience in oncology post graduate degree
  • Ability to be able to provide direction for a large scale lung cancer cohort study while incorporating strategic scientific and business goals
  • Expertise in clinical research, longitudinal research, epidemiological modeling, or computational biology preferred
  • Expertise or hands-on experience with “big data” and/or natural history data applied to oncology
  • Ability to represent the company and the lung cancer cohort findings at appropriate scientific, non-scientific, and other professional meetings
  • Ability to establish and maintain key relationships with internal and external stakeholders, including patient advocacy groups and other community-based disease focused organizations
  • Ability to lead directly and by influence, including strong problem solving and conflict resolution skills
  • Exceptional communication skills across many mediums. Demonstrated ability to communicate clearly, concisely, and empathetically to both scientific and non-scientific audiences
Responsibilities
  • provide scientific and strategic leadership for research initiatives involving our lung cancer cohort
  • responsible for the scientific success of the lung cancer research program, including developing and executing a research plan to achieve the programmatic aims
  • involved with soliciting input from key internal and external stakeholders, tracking project goals, and implementing an analysis plan
  • collaboration with an external study sponsor and their advisors

23andMe offers direct-to-consumer DNA testing that provides individuals with insights into their ancestry, genetic traits, and potential health risks. Customers purchase a DNA testing kit, send in a saliva sample, and receive personalized genetic reports based on the analysis of their DNA. This service appeals to a wide range of people, from those curious about their family history to those wanting to understand their genetic health predispositions. Unlike many competitors, 23andMe not only sells DNA kits but also offers subscription services for ongoing updates and insights, creating a recurring revenue model. Additionally, the company utilizes its large genetic database for research, partnering with institutions and pharmaceutical companies to advance genetic studies and potentially discover new treatments. The goal of 23andMe is to empower individuals with knowledge about their genetics while contributing to broader scientific research.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Sunnyvale, California

Founded

2006

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-5%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of new features like the Biological Age and Bipolar Disorder reports demonstrates 23andMe's commitment to expanding its health insights offerings.
  • Partnerships with companies like Nightingale Health and Innate Pharma highlight 23andMe's role in advancing personalized medicine and cancer treatment.
  • The company's large-scale studies, such as the LRRK2 variant research, position it as a leader in genetic research and contribute to significant scientific discoveries.

What critics are saying

  • Security breaches, like the one affecting 7 million users, pose significant risks to customer trust and data integrity.
  • The potential move to go private again could create uncertainty and instability for employees and investors.

What makes 23andMe unique

  • 23andMe's direct-to-consumer model democratizes access to genetic insights, unlike traditional genetic testing services that require medical intermediaries.
  • The company's extensive genetic database, leveraged for research partnerships, provides a unique revenue stream and accelerates genetic research.
  • 23andMe's integration of genetic and blood biomarker data through partnerships like Nightingale Health offers a more comprehensive health assessment than competitors.

Benefits

Comprehensive health, vision, & dental plans

Family planning, support, & leave for parents

Mental healthcare

Student loan assistance

Volunteer time off

Dog friendly office